☆ 4.7 Review

Insights into the Relationship between Pentraxin-3 and Cancer

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Related references

Note: Only part of the references are listed.
Editorial Material Hematology

Strengthening cancer care in Europe

[Anonymous]

LANCET HAEMATOLOGY (2023)

Add to Collection
Review Biochemical Research Methods

Point-of-care electrochemical testing of biomarkers involved in inflammatory and inflammatory-associated medical conditions

Diana-Gabriela Macovei et al.

Summary: Recent years have shown the benefits of diagnosing and monitoring biomarkers related to inflammatory medical conditions in improving healthcare and patient life quality. The development of integrated and portable point-of-care testing devices for early disease diagnosis and monitoring, even at the patient's bed, is crucial. This review focuses on the progress in detecting specific biomarkers and inflammation-related biomarkers in various diseases and provides an overview of the latest electrochemical sensors for their detection. The future perspectives of point-of-care testing to enhance healthcare management are also discussed.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2023)

Add to Collection
Article Oncology

European Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission

Mark Lawler et al.

Summary: Cancer research is vital for improving cancer care, and patients treated in research-active hospitals have better outcomes. However, the COVID-19 pandemic has negatively impacted cancer outcomes in Europe and set back progress by almost a decade. The Lancet Oncology European Groundshot Commission aims to use detailed data on cancer research to inform future cancer care strategies in Europe.

LANCET ONCOLOGY (2023)

Add to Collection
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection
Article Oncology

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

Yanyan Zhang et al.

Summary: This study elucidates the molecular mechanism by which tumorous RelB contributes to immune evasion by inhibiting T cell immunity through the amplification of the PD-L1/PD-1-mediated immune checkpoint.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Add to Collection
Review Pharmacology & Pharmacy

The Long Pentraxin PTX3 as a New Biomarker and Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy

Matteo Stravalaci et al.

Summary: Age related macular degeneration (AMD) and diabetic retinopathy (DR) are neurodegenerative and inflammatory diseases of the eye. Both diseases involve cellular components of the blood-retina barrier (BRB) and share common drivers, such as chronic inflammation. Long pentraxin 3 (PTX3), a soluble pattern recognition molecule, is emerging as a potential therapeutic target in retinal diseases, as it plays a role in trapping complement and modulating inflammation at the BRB.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection
Article Oncology

Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers

Yu-Wei Hsiao et al.

Summary: Targeting vital protumour factors found in stromal cells in the tumour microenvironment may be an effective strategy in cancer therapy. Loss of PTX3 in stromal cells has been shown to decrease the metastasis and growth of cancer cells. Clinically, stromal PTX3 expression is associated with adverse prognostic features and worse survival outcomes in TNBC. Furthermore, TGF-beta 1 induces PTX3 expression by activating CEBPD in stromal fibroblasts, leading to the metastasis and invasion of TNBC MDA-MB-231 cells.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Add to Collection
Article Oncology

European cancer mortality predictions for the year 2022 with focus on ovarian cancer

M. Dalmartello et al.

Summary: Cancer mortality rates in Europe have been decreasing over the last three decades. Lung cancer and ovarian cancer rates have decreased, while stomach cancer, colorectal cancer, breast cancer, and prostate cancer rates have shown significant declines. Leukemia and uterine cancer mortality rates have also decreased.

ANNALS OF ONCOLOGY (2022)

Add to Collection
Article Oncology

Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression

Manuela Cabiati et al.

Summary: This study aimed to identify new potential biomarkers of HCC by analyzing the expression and regulatory role of key genes through data mining. The results showed that OPN may serve as an important tumor marker and be associated with poor prognosis in HCC patients.

CLINICAL & EXPERIMENTAL METASTASIS (2022)

Add to Collection
Article Genetics & Heredity

Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer

Xinpei Gu et al.

Summary: This study identified key angiogenic factors (AFs) closely related to the development of NSCLC and constructed a novel prognostic risk model based on these factors. The model showed good discrimination and calibration, making it a valuable tool for predicting treatment prognosis in clinical practice.

FRONTIERS IN GENETICS (2022)

Add to Collection
Article Oncology

Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer

Mohammad Azhar Kamal et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor with poor treatment response. LAMC2 and PTX3, secreted by pancreatic tumors, show potential as biomarkers for the early diagnosis of PDAC.

CANCERS (2022)

Add to Collection
Article Oncology

ST08 Altered NF-kappa B Pathway in Breast Cancer Cells In Vitro as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model

Snehal Nirgude et al.

Summary: ST08, a novel curcumin derivative, exhibits anti-cancer properties by reducing tumor burden and inducing apoptosis in MDA-MB-231 triple-negative breast cancer cells, while also potentiating the effect of cisplatin with minimal toxicity.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection
Article Neurosciences

PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma

Hao Zhang et al.

Summary: The study reveals that PTX3 is upregulated in glioblastoma and is closely related to other immune-related genes in the tumor microenvironment. PTX3 is involved in regulating macrophage migration, inflammation-resolving polarization, and can predict immunotherapy response.

CNS NEUROSCIENCE & THERAPEUTICS (2022)

Add to Collection
Review Oncology

The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression

Federica Liotti et al.

Summary: The tumor microenvironment (TME) plays a crucial role in cancer progression and growth. Specialized Pro-resolving Mediators (SPMs) derived from omega-3 and omega-6 fatty acids have the ability to shape the TME and inhibit tumor growth by modulating different components of the TME.

CANCERS (2022)

Add to Collection
Review Oncology

The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer

Azin Aghamajidi et al.

Summary: The gut microbiome plays a crucial role in the development of the immune system and can impact the response to systemic treatments like immunotherapy and chemotherapy. This article provides a comprehensive overview of how the gut microbiome interacts with the immune system and cancer, and how it affects anti-tumor immunity and response to immunotherapy. Understanding these mechanisms can lead to better treatment strategies for cancer patients undergoing systemic therapy.

CANCERS (2022)

Add to Collection
Review Oncology

Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis

Barbara Lobato-Delgado et al.

Summary: This article presents the latest research results on the construction of cancer prognosis predictive models using multimodal data including clinical, molecular, and imaging data. The data processing, modelling methods, validation strategies, and the challenges and opportunities in this field are discussed. The study concludes that these multimodal models can better stratify patients and have significant implications for cancer research and the implementation of personalized medicine.

CANCERS (2022)

Add to Collection
Review Cell Biology

Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer

Jason Hongting Leung et al.

Summary: This article reviews the role of interleukin-11 (IL11) as a potential biomarker in non-small cell lung cancer (NSCLC). It identifies the need for biomarkers in NSCLC and summarizes the available information. Accumulating evidence suggests IL11 to be a potential biomarker in NSCLC patients, but further research is needed.

CELLS (2022)

Add to Collection
Review Oncology

Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer

Sara Bleve et al.

Summary: Germ cell tumors are the most common malignant tumors in male young adults, and platinum-based chemotherapy has dramatically improved the prognosis of metastatic germ cell tumor patients. The choice of medical treatment can be guided by prognosis estimation. Validated biomarkers and molecular selection of patients reflecting the pathogenesis are highly needed.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection
Review Oncology

IL-6: The Link Between Inflammation, Immunity and Breast Cancer

Juan Chen et al.

Summary: Breast cancer is a leading cause of female mortality, and IL-6 plays a crucial role in its regulation. Recent studies have shown promising outcomes for breast cancer treatment through combination therapy of IL-6 inhibitory antibodies with other drugs.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection
Review Oncology

Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression

Chun-Ye Zhang et al.

Summary: Pancreatic cancer and COVID-19 have complex interactions, with COVID-19 infection impacting pancreatic cancer progression through alteration of the gut microbiota. Increased expression of inflammatory cytokines is associated with disease severity and prognosis in both diseases. Modulation of the lung-gut-pancreas axis can enhance immunotherapy and improve prognosis.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)

Add to Collection
Review Cell Biology

Mitochondrial Epigenetics Regulating Inflammation in Cancer and Aging

Debmita Chatterjee et al.

Summary: Inflammation is a crucial factor in disease progression and epigenetic modifications can influence the occurrence and development of inflammation. Mitochondria play a key role in regulating inflammation, and mitochondrial epigenetic modifications can affect both inflammation and have an impact on cancer and aging.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Add to Collection
Review Biochemistry & Molecular Biology

Role of Interleukins and New Perspectives in Mechanisms of Resistance to Chemotherapy in Gastric Cancer

Marlena Janiczek-Polewska et al.

Summary: Inflammatory cytokines play a significant role in the mechanisms of chemoresistance and may serve as potential biomarkers for evaluating chemoresistance and influencing the management of GC treatment.

BIOMEDICINES (2022)

Add to Collection
Review Surgery

Perioperative Inflammatory Response and Cancer Recurrence in Lung Cancer Surgery: A Narrative Review

Hoon Choi et al.

Summary: Surgical resection is the main treatment for solid tumors, but cancer recurrence after surgery is common. Maintaining anti-tumor cell activity and proper levels of inflammatory mediators are crucial for preventing recurrence. Surgery itself and perioperative interventions can affect these physiological responses.

FRONTIERS IN SURGERY (2022)

Add to Collection
Review Pathology

The pathogenicity of COVID-19 and the role of pentraxin-3: An updated review study

Ria Margiana et al.

Summary: COVID-19 has become a crucial scientific issue globally, and the associated acute inflammatory reaction can lead to various complications. PTX3 can serve as a suitable marker for prognosis and treatment effectiveness, although it may also have a dual role in promoting tumor development.

PATHOLOGY RESEARCH AND PRACTICE (2022)

Add to Collection
Review Immunology

Interleukin-17 as a potential therapeutic target for chronic pain

Xiaojuan Jiang et al.

Summary: Chronic pain is a clinical challenge and a major health problem with varying impacts on quality of life. Opioids are currently used as the first-line therapy, but they often come with unwanted psychoactive side effects. Therefore, there is an urgent need for new and effective treatments for chronic pain.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection
Review Biochemistry & Molecular Biology

Inflammatory Cytokine: An Attractive Target for Cancer Treatment

Hyang-Mi Lee et al.

Summary: The relationship between inflammation and cancer has been studied extensively. Inflammatory cytokines, such as interleukins, TNF-alpha, TGF-beta, interferons, and VEGF, play a pivotal role in cancer development, prognosis, and treatment. These cytokines can either promote or inhibit cancer progression and are associated with advanced cancer stages and poor prognoses.

BIOMEDICINES (2022)

Add to Collection
Review Medicine, Research & Experimental

Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role

Hao Zhang et al.

Summary: PTX3 is an acute-phase protein that regulates innate immunity, inflammation, angiogenesis, and tissue remodeling. It has dual roles in oncogenesis and is involved in the occurrence and development of non-cancerous diseases. PTX3 expression is influenced by various factors and may serve as a potential biomarker for prognosis, activity, and severity of diseases.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection
Review Medicine, Research & Experimental

Inflammation and Gastric Cancer

Aunchalee Jaroenlapnopparat et al.

Summary: Gastric cancer remains a major global killer with a complex interaction between environmental, host genetic, and microbial factors. Chronic inflammation is closely associated with the onset of cancer, particularly gastrointestinal cancers in which microbial pathogens play a significant role in chronic inflammation. Understanding these interconnections can improve prevention and enhance our understanding of existing gastric cancer cases.

DISEASES (2022)

Add to Collection
Review Medicine, Research & Experimental

The 8th Wonder of the Cancer World: Esophageal Cancer and Inflammation

Harleen Kaur Chela et al.

Summary: Esophageal cancer is a devastating malignancy with diverse underlying factors, including inflammation. Diagnosis is based on clinical symptomatology, imaging, and endoscopy, and treatment and prognosis depend on the disease stage.

DISEASES (2022)

Add to Collection
Article Immunology

STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells

Uri Rozovski et al.

Summary: This study suggests that CLL cells can produce high levels of PTX3, and phosphorylated STAT3 can transcriptionally activate the PTX3 gene. Inhibition of PTX3 may be beneficial for CLL patients.

JOURNAL OF IMMUNOLOGY (2022)

Add to Collection
Article Biochemistry & Molecular Biology

CIRCULATING NUCLEAR FACTOR-KAPPA B MEDIATES CANCER-ASSOCIATED INFLAMMATION IN HUMAN BREAST AND COLON CANCER

Berrin Papila Kundaktepe et al.

Summary: Serum levels of NF-kβ, TNF-α, IL-6, PTX-3, PCT, and CRP were significantly increased in patients with breast and colon cancer, while serum sTRAIL levels were significantly decreased. NF-kβ was positively correlated with CRP and negatively correlated with sTRAIL. Breast and colon cancer patients exhibited increased systemic inflammation.

JOURNAL OF MEDICAL BIOCHEMISTRY (2021)

Add to Collection
Review Immunology

Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?

Benoit Brilland et al.

Summary: Pentraxins are soluble innate immunity receptors that play a role in clearing microbes and dead cells, as well as regulating complement activation, inflammation, and tissue homeostasis. Autoantibodies against pentraxins are associated with autoimmune diseases like systemic lupus erythematosus and ANCA-associated vasculitis.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Article Oncology

Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments

Xiaoying Chang et al.

Summary: Through integration and analysis of two datasets, GSE18520 and GSE26712, a total of 238 differentially expressed genes (DEGs) were screened out. WGCNA identified 15 gene modules, with the purple module showing the highest correlation with ovarian epithelial cancer. Further analysis revealed that PTX3 gene had the highest hazardous risk (HR) value and high expression of PTX3 was an independent risk factor for the prognosis of ovarian epithelial cancer patients.

CANCER CELL INTERNATIONAL (2021)

Add to Collection
Article Medicine, Research & Experimental

Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma?

Manuela Cabiati et al.

Summary: This study analyzed the expression profiles of PTX3 and NPTX2 in HCV-positive HCC patients, indicating that PTX3 could serve as a predictive biomarker and staging marker for clinical liver severity in these patients, while NPTX2 may only play a role as an inflammatory marker.

CLINICAL AND EXPERIMENTAL MEDICINE (2021)

Add to Collection
Article Oncology

Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy

Ugo Giovanni Falagario et al.

Summary: PTX3 levels in serum could be a valuable biomarker for predicting prostate biopsy results, outperforming other variables in predicting both anyPCa and csPCa. If confirmed, this novel reflex test using PTX3 could help in reducing unnecessary prostate biopsies.

CANCERS (2021)

Add to Collection
Article Oncology

A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing

Fan Fan et al.

Summary: This study identified 7 prognostic marker genes for GBM through data mining and single-cell sequencing, and built a prognostic model based on these genes. The identified genes were associated with tumor proliferation and progression.

CELLULAR ONCOLOGY (2021)

Add to Collection
Article Immunology

PTX3 Regulation of Inflammation, Hemostatic Response, Tissue Repair, and Resolution of Fibrosis Favors a Role in Limiting Idiopathic Pulmonary Fibrosis

Andrea Doni et al.

Summary: PTX3 is a soluble pattern recognition molecule involved in the humoral innate immune system and plays a crucial role in wound repair by facilitating ECM clearance. Studies suggest that PTX3 may have a significant role in the development of IPF and could be a potential target for therapeutic intervention.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Article Oncology

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma

Michelle R. Goulart et al.

Summary: PTX3 is a potential stromal-derived biomarker for PDAC, with higher sensitivity and specificity for detection, and can impact its secretion and evolution by modulating PSC activity through ATRA. These research findings are expected to be further validated in clinical trials.

NPJ PRECISION ONCOLOGY (2021)

Add to Collection
Article Cell Biology

In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer

Soulaimane Aboulouard et al.

Summary: The study identifies significant variations in the SLN protein landscape in EC and shows correlation between SLN and tumor grade, emphasizing the potential of certain proteins as markers for overall survival. Five major proteins for EC and SLN were identified and validated, improving stratification and diagnosis of individuals with EC.

CELL REPORTS MEDICINE (2021)

Add to Collection
Article Oncology

Pentraxin-3 inhibits milky spots metastasis of gastric cancer by inhibiting M2 macrophage polarization

Xinye Cui et al.

Summary: Recent studies have shown that Pentraxin-3 (PTX3) is associated with invasion, migration, and metastasis of gastric cancer cells (GCCs). This study found that PTX3 is lowly expressed in gastric carcinoma tissues and influences the stemness and macrophage polarization. Upregulation of PTX3 inhibits stemness of GCCs and suppresses M2 macrophage polarization in milky spots, leading to a reduction in gastric cancer metastasis.

JOURNAL OF CANCER (2021)

Add to Collection
Article Medicine, General & Internal

Impact of pentraxin 3 genetic variants on uterine cervical cancer clinicopathologic characteristics

Yi-Hung Sun et al.

Summary: PTX3 genetic variants are not associated with the pathogenesis, clinicopathological variables, and patient survival of uterine cervical cancer in Taiwanese women. The only independent predictor for 5 years survival is pelvic lymph node metastasis.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)

Add to Collection
Article Oncology

Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers

Marianne E. Nome et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Add to Collection
Article Medicine, Research & Experimental

Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients

Susanne Feder et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2020)

Add to Collection
Article Cell Biology

PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma

Giuseppe Stefano Netti et al.

AGING-US (2020)

Add to Collection
Review Agronomy

The Role of Pentraxin 3 in Aspergillosis: Reality and Prospects

Yuening Kang et al.

MYCOBIOLOGY (2020)

Add to Collection
Article Biotechnology & Applied Microbiology

Pentraxin 3 (PTX-3) Levels in Bronchoalveolar Lavage Fluid as a Lung Cancer Biomarker

Tinghua Hu et al.

DISEASE MARKERS (2020)

Add to Collection
Article Clinical Neurology

Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas

Stine Asferg Petterson et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)

Add to Collection
Article Multidisciplinary Sciences

Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

Hemant M. Kocher et al.

NATURE COMMUNICATIONS (2020)

Add to Collection
Review Immunology

The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression

Zeyu Wang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection
Article Multidisciplinary Sciences

Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection

Huan Deng et al.

SCIENTIFIC REPORTS (2020)

Add to Collection
Article Multidisciplinary Sciences

Modulation of complement activation by pentraxin-3 in prostate cancer

Giovanni Stallone et al.

SCIENTIFIC REPORTS (2020)

Add to Collection
Article Oncology

Cytokine TNF-α promotes invasion and metastasis of gastric cancer by down-regulating Pentraxin3

Xinye Cui et al.

JOURNAL OF CANCER (2020)

Add to Collection
Article Oncology

Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition

Manuel Scimeca et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)

Add to Collection
Review Immunology

Pentraxin 3 in Cardiovascular Disease

Giuseppe Ristagno et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection
Review Immunology

The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer

Andrea Doni et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection
Article Oncology

Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression

Sara Matarazzo et al.

CANCERS (2019)

Add to Collection
Review Oncology

Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance

Weihua Zhou et al.

CANCERS (2019)

Add to Collection
Review Immunology

The Long Pentraxin PTX3 in Bone Homeostasis and Pathology

Raffaella Parente et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection
Article Medicine, General & Internal

18F-Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers

Nicoletta Urbano et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Add to Collection
Article Oncology

IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K/Akt1/NF-κB-p65

Bin Wang et al.

CANCER LETTERS (2019)

Add to Collection
Article Cell Biology

Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-B- and HIF-1-mediated downregulation of PTX3

Bulbul Ahmmed et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Add to Collection
Article Physiology

Low Expression of Pentraxin 3 and Nuclear Factor-Like 2 Implying a Relatively Longer Overall Survival Time in Gliomas

Hui-Hsuan Ke et al.

CHINESE JOURNAL OF PHYSIOLOGY (2019)

Add to Collection
Review Biochemistry & Molecular Biology

Long pentraxin 3: A novel multifaceted player in cancer

Arianna Giacomini et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Add to Collection
Article Oncology

Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease

Janna Berg et al.

BMC CANCER (2018)

Add to Collection
Article Oncology

Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer

Manuel Scimeca et al.

CLINICAL BREAST CANCER (2018)

Add to Collection
Article Biotechnology & Applied Microbiology

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy

Nice Bedini et al.

DISEASE MARKERS (2018)

Add to Collection
Article Medicine, Research & Experimental

Soluble stroma-related biomarkers of pancreatic cancer

Andrea Resovi et al.

EMBO MOLECULAR MEDICINE (2018)

Add to Collection
Letter Hematology

Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy

Anne-Sophie Brunel et al.

HAEMATOLOGICA (2018)

Add to Collection
Article Oncology

Radiological, Histological and Chemical Analysis of Breast Microcalcifications: Diagnostic Value and Biological Significance

Rita Bonfiglio et al.

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2018)

Add to Collection
Article Anatomy & Morphology

Calcifications in prostate cancer: An active phenomenon mediated by epithelial cells with osteoblast-phenotype

Manuel Scimeca et al.

MICROSCOPY RESEARCH AND TECHNIQUE (2018)

Add to Collection
Review Physiology

PTX3, A HUMORAL PATTERN RECOGNITION MOLECULE, IN INNATE IMMUNITY, TISSUE REPAIR, AND CANCER

Cecilia Garlanda et al.

PHYSIOLOGICAL REVIEWS (2018)

Add to Collection
Review Gastroenterology & Hepatology

Biomarkers of gastric cancer: Current topics and future perspective

Tasuku Matsuoka et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Add to Collection
Letter Hematology

Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy

Anne-Sophie Brunel et al.

HAEMATOLOGICA (2018)

Add to Collection
Article Oncology

Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition

Tao Song et al.

JOURNAL OF CANCER (2018)

Add to Collection
Article Biochemistry & Molecular Biology

MicroRNA-224 inhibition prevents progression of cervical carcinoma by targeting PTX3

Li-Mei Yu et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Add to Collection
Article Immunology

Polymorphisms in Receptors Involved in Opsonic and Nonopsonic Phagocytosis, and Correlation with Risk of Infection in Oncohematology Patients

M. Carmen Herrero-Sanchez et al.

INFECTION AND IMMUNITY (2018)

Add to Collection
Article Medicine, General & Internal

Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study

Bin Liu et al.

MEDICINE (2018)

Add to Collection
Review Immunology

Pentraxins in Complement Activation and Regulation

Ying Jie Ma et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection
Review Immunology

The Influence of Pentraxin 3 on the Ovarian Function and Its Impact on Fertility

Antonella Camaioni et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection
Article Oncology

Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth

Priscila Fabiana Rodrigues et al.

FRONTIERS IN ONCOLOGY (2018)

Add to Collection
Article Oncology

Accumulated promoter methylation as a potential biomarker for esophageal cancer

Xianzhen Peng et al.

ONCOTARGET (2017)

Add to Collection
Article Oncology

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer

Line Jee Hartmann Rasmussen et al.

INTERNATIONAL JOURNAL OF CANCER (2017)

Add to Collection
Article Biochemistry & Molecular Biology

Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers

Clemence Thomas et al.

SCIENCE SIGNALING (2017)

Add to Collection
Article Oncology

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer

Roberto Ronca et al.

ONCOTARGET (2017)

Add to Collection
Article Biochemistry & Molecular Biology

Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers

Clemence Thomas et al.

SCIENCE SIGNALING (2017)

Add to Collection
Article Oncology

Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer

Marcello Rubino et al.

ONCOIMMUNOLOGY (2017)

Add to Collection
Article Multidisciplinary Sciences

Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism

Jiwoo Lee et al.

PLOS ONE (2017)

Add to Collection
Article Immunology

C-reactive protein (CRP) but not the related pentraxins serum amyloid P and PTX3 inhibits the proliferation and induces apoptosis of the leukemia cell line Mono Mac 6

Wensheng Chen et al.

BMC IMMUNOLOGY (2017)

Add to Collection
Review Oncology

The role of Nuclear Factor-kappa B signaling in human cervical cancer

Sam Tilborghs et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Add to Collection
Article Oncology

Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients

Maurizio Infante et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

Add to Collection
Article Gastroenterology & Hepatology

Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV

R. F. Carmo et al.

JOURNAL OF VIRAL HEPATITIS (2016)

Add to Collection
Article Oncology

Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers

Manuel Scimeca et al.

TUMOR BIOLOGY (2016)

Add to Collection
Article Endocrinology & Metabolism

Serum pentraxin 3 as a possible marker for mature cystic teratomas

Chiharu Ishida et al.

GYNECOLOGICAL ENDOCRINOLOGY (2016)

Add to Collection
Article Immunology

The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells

Alejo Chorny et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Add to Collection
Correction Multidisciplinary Sciences

Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer (vol 11, e0148186, 2016)

Giuseppe Di Caro et al.

PLOS ONE (2016)

Add to Collection
Article Medicine, General & Internal

Increased Plasma Levels of Pentraxin 3 Are Associated with Poor Prognosis of Colorectal Carcinoma Patients

Jie Zhang et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Add to Collection
Article Gastroenterology & Hepatology

Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer

Masakazu Yashiro et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Add to Collection
Article Oncology

Upregulation of brain-derived neurotrophic factor in advanced gastric cancer contributes to bone metastatic osteolysis by inducing long pentraxin 3

Bongkun Choi et al.

ONCOTARGET (2016)

Add to Collection
Article Multidisciplinary Sciences

Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling

Goparaju Chandrika et al.

SCIENTIFIC REPORTS (2016)

Add to Collection
Article Immunology

Expression of Pentraxin 3 and Thrombospondin 1 in Gingival Crevicular Fluid during Wound Healing after Gingivectomy in Postorthodontic Patients

Anne Marie Rauten et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2016)

Add to Collection
Article Multidisciplinary Sciences

Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8

YongJie Huang et al.

PLOS ONE (2016)

Add to Collection
Article Multidisciplinary Sciences

Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells

Tsung-Ho Ying et al.

SCIENTIFIC REPORTS (2016)

Add to Collection
Article Biochemistry & Molecular Biology

PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer

Eduardo Bonavita et al.

CELL (2015)

Add to Collection
Article Oncology

Conditionally immortalized human pancreatic stellate cell lines demonstrate enhanced proliferation and migration in response to IGF-I

Ann H. Rosendahl et al.

EXPERIMENTAL CELL RESEARCH (2015)

Add to Collection
Article Microbiology

Regulation of HBV-specific CD8+ T cell-mediated inflammation is diversified in different clinical presentations of HBV infection

Colin M. Dinney et al.

JOURNAL OF MICROBIOLOGY (2015)

Add to Collection
Article Biochemistry & Molecular Biology

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling

Evan M. Cherry et al.

MOLECULAR CANCER (2015)

Add to Collection
Article Oncology

PTX3 gene activation in EGF-induced head and neck cancer cell metastasis

Wei-Chiao Chang et al.

ONCOTARGET (2015)

Add to Collection
Article Oncology

Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma

Akiko Kawano Nagatsuma et al.

GASTRIC CANCER (2015)

Add to Collection
Article Obstetrics & Gynecology

Analyzing the differentially expressed genes and pathway cross-talk in aggressive breast cancer

Wen-Yan Chen et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2015)

Add to Collection
Article Oncology

Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer

Giovanni Stallone et al.

CANCER RESEARCH (2014)

Add to Collection
Review Biochemistry & Molecular Biology

Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers

Hua-Hsi Wu et al.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2014)

Add to Collection
Article Biochemistry & Molecular Biology

microRNA-224 regulates Pentraxin 3, a component of the humoral arm of innate immunity, in inner ear inflammation

Anya Rudnicki et al.

HUMAN MOLECULAR GENETICS (2014)

Add to Collection
Review Allergy

The Long Pentraxin PTX3 as a Key Component of Humoral Innate Immunity and a Candidate Diagnostic for Inflammatory Diseases

Sebastien Jaillon et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2014)

Add to Collection
Article Cell Biology

Nrf2 expression participates in growth and differentiation of endometrial carcinoma cells in vitro and in vivo

Kainan Li et al.

JOURNAL OF MOLECULAR HISTOLOGY (2014)

Add to Collection
Article Medicine, General & Internal

Role of PTX3 in pancreatic cancer

Jennifer Watt et al.

LANCET (2014)

Add to Collection
Article Oncology

Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer

Chao Liu et al.

MEDICAL ONCOLOGY (2014)

Add to Collection
Article Biochemistry & Molecular Biology

AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells

M. K. Asiedu et al.

ONCOGENE (2014)

Add to Collection
Article Pathology

Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma

Y. Soini et al.

PATHOLOGY RESEARCH AND PRACTICE (2014)

Add to Collection
Article Pathology

FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation

Guy Betts et al.

VIRCHOWS ARCHIV (2014)

Add to Collection
Article Gastroenterology & Hepatology

MicroRNAs as potential biomarkers for gastric cancer

Han-Shao Liu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Add to Collection
Article Oncology

Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function

Bongkun Choi et al.

ONCOTARGET (2014)

Add to Collection
Article Oncology

Clinical Significance and Prognostic Value of Pentraxin-3 as Serologic Biomarker for Lung Cancer

Dai Zhang et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)

Add to Collection
Article Oncology

Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer

Y. Okugawa et al.

BRITISH JOURNAL OF CANCER (2013)

Add to Collection
Article Oncology

A prospective study of plasma inflammatory markers and risk of colorectal cancer in men

M. Song et al.

BRITISH JOURNAL OF CANCER (2013)

Add to Collection
Article Oncology

Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma

S. Kondo et al.

BRITISH JOURNAL OF CANCER (2013)

Add to Collection
Article Gastroenterology & Hepatology

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

Abasi Ene-Obong et al.

GASTROENTEROLOGY (2013)

Add to Collection
Article Pathology

Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma

Tomonori Sasahira et al.

HUMAN PATHOLOGY (2013)

Add to Collection
Article Oncology

Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo

Li-Sha Ai et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

Add to Collection
Article Immunology

The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas

Marco Locatelli et al.

JOURNAL OF NEUROIMMUNOLOGY (2013)

Add to Collection
Article Oncology

Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer

Roberto Ronca et al.

JOURNAL OF PATHOLOGY (2013)

Add to Collection
Article Multidisciplinary Sciences

Pentraxin 3 (PTX3) Is Associated with Severe Sepsis and Fatal Disease in Emergency Room Patients with Suspected Infection: A Prospective Cohort Study

Raija Uusitalo-Seppala et al.

PLOS ONE (2013)

Add to Collection
Article Biochemical Research Methods

Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer

Maria P. Pavlou et al.

PROTEOMICS (2013)

Add to Collection
Article Mathematical & Computational Biology

Identifying MicroRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis

Jihong Fu et al.

BMC SYSTEMS BIOLOGY (2012)

Add to Collection
Article Oncology

Serum Interleukin-6, Insulin, and HOMA-IR in Male Individuals with Colorectal Adenoma

Yu Sasaki et al.

CLINICAL CANCER RESEARCH (2012)

Add to Collection
Article Pathology

Discriminating thyroid cancers from benign lesions based on differential expression of a limited set of miRNA using paraffin embedded tissues

Rekha Pai et al.

INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2012)

Add to Collection
Article Urology & Nephrology

Diagnostic Potential of Urinary α1-Antitrypsin and Apolipoprotein E in the Detection of Bladder Cancer

Virginia Urquidi et al.

JOURNAL OF UROLOGY (2012)

Add to Collection
Article Multidisciplinary Sciences

A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer

Steve Goodison et al.

PLOS ONE (2012)

Add to Collection
Article Multidisciplinary Sciences

Inhibition of BDNF in Multiple Myeloma Blocks Osteoclastogenesis via Down-Regulated Stroma-Derived RANKL Expression Both In Vitro and In Vivo

Li-Sha Ai et al.

PLOS ONE (2012)

Add to Collection
Article Gastroenterology & Hepatology

Retinoic Acid-Induced Pancreatic Stellate Cell Quiescence Reduces Paracrine Wnt-β-Catenin Signaling to Slow Tumor Progression

Fieke E. M. Froeling et al.

GASTROENTEROLOGY (2011)

Add to Collection
Article Biochemistry & Molecular Biology

Heterocomplexes of Mannose-binding Lectin and the Pentraxins PTX3 or Serum Amyloid P Component Trigger Cross-activation of the Complement System

Ying Jie Ma et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Add to Collection
Article Oncology

Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors

Daria Leali et al.

MOLECULAR CANCER THERAPEUTICS (2011)

Add to Collection
Article Genetics & Heredity

Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention?

Yu Wang et al.

EPIGENOMICS (2011)

Add to Collection
Article Oncology

Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway

Amit Gokhale et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2010)

Add to Collection
Article Oncology

Neurotrophic Receptor, Tropomyosin-Related Kinase B as an Independent Prognostic Marker in Gastric Cancer Patients

Koji Tanaka et al.

JOURNAL OF SURGICAL ONCOLOGY (2009)

Add to Collection
Article Oncology

Cancer-associated stroma fibroblasts promote pancreatic tumor progression

Rosa F. Hwang et al.

CANCER RESEARCH (2008)

Add to Collection
Article Biochemistry & Molecular Biology

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

Manav Korpal et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Add to Collection
Article Oncology

Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients

Eva Lieto et al.

ANNALS OF SURGICAL ONCOLOGY (2008)

Add to Collection
Review Medicine, Research & Experimental

The pancreatic stellate cell: a star on the rise in pancreatic diseases

M. Bishr Omary et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Add to Collection
Review Immunology

NFκB:: Linking inflammation and immunity to cancer development and progression

M Karin et al.

NATURE REVIEWS IMMUNOLOGY (2005)

Add to Collection
Article Hematology

Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis

M Rusnati et al.

BLOOD (2004)

Add to Collection
Article Oncology

Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging

JB O'Connell et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.